NeuroOne entered a Southern California distribution agreement to expand U.S. commercialization of its FDA-cleared OneRF Trigeminal Nerve Ablation System.
The deal covers key counties including the Los Angeles metropolitan area, widening physician access in a major U.S. market.
The agreement supports a broader push to build a U.S. distribution network, with additional distributor relationships under evaluation.
NMTC•
